Microglial apolipoprotein E and astroglial apolipoprotein J expression in vitro: Opposite effects of lipopolysaccharide

Journal of Neurochemistry

Volumn 85, Issue 6, 2003, Pages 1455-1467

  Saura, Josep ^a,b   Petegnief, Valerie ^b   Wu, Xin ^b   Liang, Yanbin ^b   Paul, Steven M ^a,b  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ELI LILLY AND COMPANY   (United States)

Author keywords

Apolipoprotein E; Apolipoprotein J; Astrocytes; Glial activation; Microglia; NF B

Indexed keywords

APOLIPOPROTEIN A; CLUSTERIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE;

ANIMAL CELL; ARTICLE; ASTROCYTE; BRAIN CORTEX; CELL CULTURE; CELL TYPE; CONTROLLED STUDY; DOSE RESPONSE; IN VITRO STUDY; IN VIVO STUDY; MACROGLIA; METABOLIC REGULATION; MICROGLIA; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; RAT;

ANIMALIA;

EID: 0038810288     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2003.01788.x     Document Type: Article

References (72)

1. Akama K. T. and Van Eldik L. J. (2000) β-Amyloid stimulation of inducible nitric-oxide synthase in astrocytes is interleukin-1β-and tumor necrosis factor-α (TNFα)-dependent, and involves a TNFα receptor-associated factor- and NF-κB-inducing kinase-dependent signaling mechanism. J. Biol. Chem. 275, 7918-7924.
2. Akama K. T., Albanese C., Pestell R. G. and Van Eldik L. J. (1998) Amyloid β-peptide stimulates nitric oxide production in astrocytes through an NF-κB-dependent mechanism. Proc. Natl Acad. Sci. USA 95, 5795-5800.
3. Bales K. R., Verina T., Dodel R. C., Du Y., Altstiel L., Bender M., Hyslop P., Johnstone E. M., Little S. P., Cummins D. J., Piccardo P., Ghetti B. and Paul S. M. (1997) Lack of apolipoprotein E dramatically reduces amyloid beta-peptide deposition. Nat. Gen. 17, 263-264.
4. Bales K. R., Du Y., Dodel R. C., Yan G. M., Hamilton-Byrd E. and Paul S. M. (1998) The NF-κB/Rel family of proteins mediates Aβ-induced neurotoxicity and glial activation. Mol. Brain Res. 57, 63-72.
5. Bales K. R., Xu Q., Du Y., Naidu A., Cordell B. and Paul S. M. (1999a) Amyloid-β peptide stimulates apolipoprotein E synthesis and release in a murine microglial cell line via an NF-κB-dependent mechanism. Soc. Neurosci. Abstract 12, 11.
6. Bales K. R., Verina T., Cummins D. J., Du Y., Dodel R. C., Saura J., Fishman C. E., Delong C. A., Piccardo P., Petegnief V., Ghetti B. and Paul S. M. (1999b) Apolipoprotein E is essential for amyloid deposition in the APPV717F transgenic mouse model of Alzheimer's disease. Proc. Natl Acad. Sci. USA 96, 15233-15238.
7. Baskin F., Smith G. M., Fosmire J. A. and Rosenberg R. N. (1997) Altered apolipoprotein E secretion in cytokine-treated human astrocyte cultures. J. Neurol. Sci. 148, 15-18.
8. Bauerle P. A. (1998) Proinflammatory signaling: last pieces in the NF-κB puzzle? Current. Biol. 8, R19-R22.
9. Boje K. M. and Arora P. K. (1992) Microglial-produced nitric oxide and reactive nitrogen oxides mediate neuronal cell death. Brain Res. 7, 250-256.
10. Bonaiuto C., McDonald P. P., Rossi F. and Cassatella M. A. (1997) Activation of nuclear factor-κB by β-amyloid peptides and interferon-γ in murine microglia. J. Neuroimmunol. 77, 51-56.
11. Boyles J. K., Pitas R. E., Wilson E., Mahley R. W. and Taylor J. M. (1985) Apolipoprotein E associated with astrocytic glia of the central nervous system and with nonmyelinating glia of the peripheral nervous system. J. Clin. Invest. 76, 1501-1513.
12. Casal C., Tusell J. M. and Serratosa J. (2001) Role of calmodulin in the differentiation/activation of microglial cells. Brain Res. 902, 101-107.
13. Danik M., Chabot J. G., Hassan-Gonzalez D., Suh M. and Quirion R. (1993) Localization of sulfated glycoprotein-2/clusterin mRNA in the rat brain by in situ hybridization. J. Comp. Neurol. 334, 209-227.
14. Danik M., Chabot J. G., Michel D. and Quirion R. (1999) Clusterin and apolipoprotein E gene expression in the adult brain. In: Clusterin in Normal Brain Functions and During Neurodegeneration (Finch, C. E., ed.), pp. 17-34. RG Landes Company, Austin.
15. DeMattos R. B., O'dell M. A., Parsadanian M., Taylor J. W., Harmony J. A. K., Bales K. G., Paul S. M., Aronow B. J. and Holtzman D. M. (2002) Clusterin promotes amyloid plaque formation and is critical for neuritic toxicity in a mouse model of Alzheimer's disease. Proc. Natl Acad. Sci. USA 99, 10843-10848.
16. Diedrich J. F., Minnigan H., Carp R. I., Whitaker J. N., Race R., Frey I. I. W. and Haase A. T. (1991) Neuropathological changes in scarpie and Alzheimer's disease are associated with increased expression of apolipoprotein E and cathepsin D in astrocytes. J. Virol. 65, 4759-4768.
17. Elshourbagy N. A., Liao W. S., Mahley R. W. and Taylor J. M. (1985) Apolipoprotein E mRNA is abundant in the brain and adrenals, as well as in the liver, and is present in other peripheral tissues of rats and marmosets. Proc. Natl Acad. Sci. USA 82, 203-207.
18. Ferrari D., Wesselborg S., Bauer M. K. A. and Schulze-Osthoff K. (1997) Extracellular ATP activates transcription factor NF-κB through the P2Z purinoreceptor by selectively targeting NF-κB p65 (RelA). J. Cell Biol. 139, 1635-1643.
19. Garden G. A., Bothwell M. and Rubel E. W. (1991) Lack of correspondence between mRNA expression for a putative cell death molecule (SGP-2) and neuronal cell death in the central nervous system. J. Neurobiol. 22, 590-604.
20. Giulian D. and Baker T. J. (1986) Characterization of ameboid microglia isolated from developing mammalian brain. J. Neurosci. 6, 2163-2178.
21. Glenn J. A., Ward S. A., Stone C. R., Booth P. L. and Thomas W. E. (1992) Characterisation of ramified microglial cells: detailed morphology, morphological plasticity and proliferative capability. J. Anat 180, 109-118.
22. Golabek A., Marques M. A., Lalowski, M. and Wisniewski T. (1995) Amyloid β binding proteins in vitro and in normal human cerebrospinal fluid. Neurosci. Lett. 191, 79-82.
23. Grilli M., Pizzi M., Memorandum M. and Spano P. (1996) Neuroprotection by aspirin and sodium salicylate through blockade of NF-κB activation. Science 274, 1383-1385.
24. Hardardottir I., Sipe J., Moser A. H., Fielding C. J., Feingold K. R. and Grunfeld C. (1997) LPS and cytokines regulate extra hepatic mRNA levels of apolipoproteins during the acute phase response in Syrian hamsters. Biochim. Biophys. Acta 1344, 210-220.
25. Holtzman D. M., Bales K. R., Wu S., Bhat P., Parsadanian M., Fagan A. M., Chang L. K., Sun Y. and Paul S. M. (1999a) Expression of human apolipoprotein E reduces amyloid-β deposition in a mouse model of Alzheimer's disease. J. Clin. Invest. 103, R15-R21.
26. Holtzman D. M., LaDu M. J. and Sagan A. M. (1999b) Clusterin-apoE lipoprotein particles. In: Clusterin in Normal Brain Functions and During Neurodegeneration (Finch C. E., ed.), pp. 61-69. RG Landes Company, Austin.
27. Holtzman D. M., Bales K. R., Tenkova T., Fagan A. M., Parsadanian M., Sartorius L. J., Mackey B., Olney J., McKeel D., Wozniak D. and Paul S. M. (2000) Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer's disease. Proc. Natl Acad. Sci. USA 97, 2892-2897.
28. Kida E., Golabek A. A., Wisniewski T. and Wisniewski K. E. (1994) Regional differences in apolipoprotein E immunoreactivity in diffuse plaques in Alzheimer's disease brain. Neurosci. Lett. 167, 73-76.
29. Kong L. Y., Lai C., Wilson B. C., Simpson J. N. and Hong J. S. (1997) Protein tyrosine kinase inhibitors decrease lipopolysaccharide-induced proinflammatory cytokine production in mixed glia, microglia-enriched or astrocyte-enriched cultures. Neurochem. Int. 30, 491-497.
30. Kounnas M. Z., Haudenschild C. C., Strickland D. K. and Argraves W. S. (1994) Immunological localization of glycoprotein 330, low density lipoprotein receptor related protein and 39-kDa receptor-associated protein in embryonic mouse tissues. In vivo 8, 343-351.
31. Kounnas M. Z., Loukinova E. B., Stefansson S., Harmony J. A., Brewer B. H., Strickland D. K. and Argraves W. S. (1995) Identification of glycoprotein 330 as an endocytic receptor for apolipoprotein J/clusterin. J. Biol. Chem. 270, 13070-13075.
32. LaDu M. J., Shah J. A., Reardon C. A., Getz G. S., Bu G., Hu J., Guo L. and van Eldik L. J. (2000) Apolipoprotein E receptors mediate the effects of β-amyloid on astrocyte cultures. J. Biol. Chem. 275, 33974-33980.
33. Lee S. C., Liu W., Brosnan C. F. and Dickson D. W. (1994) GM-CSF promotes proliferation of human fetal and adult microglia in primary cultures. Glia 12, 309-318.
34. Lieberman A. P., Pitha P. M., Shin H. S. and Shin M. L. (1989) Production of tumor necrosis factor and other cytokines by astrocytes stimulated with lipopolysaccharide or a neurotropic virus. Proc. Natl Acad. Sci. USA. 86, 6348-6352.
35. Lorent K., Overbergh L., Moechars D., De Strooper B., Van Leuven F. and Van den Berghe H. (1995) Expression in mouse embryos and in adult mouse brain of three members of the amyloid precursor protein family, of the α-2-macroglobulin receptor/low density lipoprotein receptor-related protein and of its ligands apolipoprotein E, lipoprotein lipase, α-2-macroglobulin and the 40 000 molecular weight receptor-associated protein. Neuroscience 65, 1009-1025.
36. Matsubara E., Soto C., Governale S., Frangione B. and Ghiso J. (1996) Apolipoprotein J and Alzheimer's amyloid β solubility. Biochem. J. 316, 671-679.
37. Menju M., Tajima S. and Yamamoto A. (1989) Expression of apolipoprotein E gene in a human macrophage-like cell line, THP-1. J. Biochem. 106, 505-510.
38. Messmer-Joudrier S., Sagot Y., Mattenberger L., James R. W. and Kato A. C. (1996) Injury-induced synthesis and release of apolipoprotein E and clusterin from rat neural cells. Eur. J. Neurosci. 8, 2652-2661.
39. Mouchel Y, Lefrancois T., Fages C. and Tardy M. (1995) Apolipoprotein E gene expression in astrocytes: developmental pattern and regulation. Neuroreport 7, 205-208.
40. Murakami M., Ushio Y., Morino Y., Ohta T. and Matsukado Y. (1988) Immunohistochemical localization of apolipoprotein E in human glial neoplasms. J. Clin. Invest. 82, 177-188.
41. Nakai M., Kawamata T., Taniguchi T., Maeda K. and Tanaka C. (1996) Expression of apolipoprotein E mRNA in rat microglia. Neurosci. Lett. 211, 41-44.
42. Namba Y., Tomonaga M., Kawasaki H., Otomo E. and Ikeda K. (1991) Apoliprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeld-Jakob disease. Brain Res. 541, 163-166.
43. Nasuhara Y., Adcock I. M., Catley M., Bames P. J. and Newton R. (1999) Differential I-κB kinase activation and I-κB-α degradation by interleukin-1β and tumor necrosis factor-α in human U937 monocytic cells. J. Biol. Chem. 274, 19965-19972.
44. Nishiya T., Uehara T. and Nomura Y. (1995) Herbimycin A suppresses NF-κB activation and tyrosine phosphorylation of JAK2 and the subsequent induction of nitric oxide synthase in C6 glioma cells. FEBS Lett. 371, 333-336.
45. O'Neill L. A. J. and Kaltschmidt C. (1997) NF-κB: a crucial transcription factor for glial and neuronal cell function. Trends Neurosci. 20, 252-258.
46. Oda T., Wals P., Osterburg H. H., Johnson S. A., Pasinetti G. M., Morgan T. E., Rozovsky I., Stine W. B., Snyder S. W., Holtzman T. F., Kraffi G. A. and Finch C. E. (1995) Clusterin (apoJ) alters the aggregation of amyloid β-peptide (Aβ1-42) and forms slowly sedimenting Aβ complexes that cause oxidative stress. Exp. Neurol. 136, 22-31.
47. Page K. J., Hollister R. D. and Hyman B. T. (1998) Dissociation of apolipoprotein and apolipoprotein receptor response to lesion in the rat brain: an in situ hybridization study. Neuroscience 85, 1161-1171.
48. Pahan K., Sheikh F. G., Namboodiri A. M. S. and Singh I. (1997) Lovastatin and phenylacetate inhibit the induction of nitric oxide synthase and cytokines in rat primary astrocytes, microglia, and macrophages. J. Clin. Invest. 100, 2671-2679.
49. Palombella V. J., Rando O. J., Goldberg A. L. and Maniatis T. (1994) The ubiquitin-proteasome pathway is required for processing the NF-κB1 precursor protein and the activation of the NF-κB. Cell 78, 773-785.
50. Pasinetti G. M., Johnson S. A., Oda T., Rozovsky I. and Finch C. E. (1994) Clusterin (SGP-2): a multifunctional glycoprotein with regional expression in astrocytes and neurons of the adult rat brain. J. Comp. Neurol. 339, 387-400.
51. Petegnief V., Saura J., De-Gregorio-Rocasolano N. and Paul S. M. (2001) Neuronal injury-induced expression and release of apolipoprotein E in mixed neuron/glia co-cultures: nuclear factor kappa B inhibitors reduce basal and lesion-induced secretion of apolipoprotein E. Neuroscience 104, 223-234.
52. 2. Proc. Natl Acad. Sci. USA 96, 4668-4673.
53. Pitas R. E., Boyles J. K., Lee S. H., Foss D. and Mahley R. W. (1987) Astrocytes synthesize apolipoprotein E and metabolize apolipoprotein E-containing lipoproteins. Biochim. Biophys. Acta 917, 148-161.
54. Poirier J., Hess M., May P. C. and Finch C. E. (1991) Astrocytic apolipoprotein E mRNA and GFAP mRNA in hippocampus after entorhinal cortex lesioning. Mol. Brain Res. 11, 97-106.
55. Quandt K., Frech K., Karas H., Wingender E. and Werner T. (1995) MatInd and MatInspector: new fast and versatile tools for detection of consensus matches in nucleotide sequence data. Nucleic Acids Res. 23, 4878-4884.
56. Schauwecker P. E., Cogen J. P., Jiang T., Cheng H. W., Collier T. J. and McNeill T. H. (1998) Differential regulation of astrocytic mRNAs in the rat striatum after lesions of the cortex or substantia nigra. Exp. Neurol. 149, 87-96.
57. Schmechel D. E., Tiller M. O., Tong P., McSwain M., Han S. H., Ange R., Burkhart D. S. and Izard M. K. (1996) Pattern of apolipoprotein E immunoreactivity during brain aging. In: Apolipoprotein E and Alzheimer's Disease (Roses A. D., Weisgraber K. H., Christen Y., eds), pp. 29-48. Springer-Verlag, Berlin.
58. Shao Y., Gearing M. and Mirra S. S. (1997) Astrocyte-apolipoprotein E associations in senile plaques in Alzheimer disease and vascular regions: a regional immunohistochemical study. J. Neuropathol. Exp. Neurol. 56, 376-381.
59. de Silva H. V., Harmony J. A., Stuart W. D., Gil C. M. and Robbins J. (1990) Apolipoprotein J: structure and tissue distribution. Biochemistry 29, 5380-5389.
60. Stone D. J., Rozovsky I., Morgan T. E., Anderson C. P., Hajian H. and Finch C. E. (1997) Astrocytes and microglia respond to estrogen with increased apoE mRNA in vivo and in vitro. Exp. Neurol. 143, 313-318.
61. Strittmatter W. J., Weisgraber K. H., Huang D. Y., Dong L. M., Salvesen G. S., Pericak-Vance M., Schmechel D., Saunders A. M., Goldgaber D. and Roses A. D. (1993) Binding of human apolipoprotein E to synthetic amyloid β peptide: isoform-specific effects and implication for late-onset Alzheimer disease. Proc. Natl Acad. Sci. USA 90, 8098-8102.
62. Suzumura A., Marunouchi T. and Yamamoto H. (1991) Morphological transformation of microglia in vitro. Brain Res. 545, 301-306.
63. Tanaka C., Kamata H., Takeshita H., Yagisawa H. and Hirata H. (1997) Redox regulation of lipopolysaccharide (LPS)-induced interleukin-8 (IL-8) gene expression mediated by NF-κB and AP-1 in human astrocytoma U373 cells. Biochem. Biophys. Res. Commun. 232, 568-573.
64. Uchihara T., Duyckaerts C., He Y., Kobayashi K., Seilhean D., Amouyel P. and Hauw J. J. (1995) ApoE immunoreactivity and microglial cells in Alzheimer's disease brain. Neurosci. Lett. 195, 5-8.
65. Werb Z. and Chin J. R. (1983) Endotoxin suppresses expression of apolipoprotein E by mouse macrophages in vivo and in cultures. J. Biol. Chem. 258, 10642-10648.
66. White F., Nicoll J. A. and Horsburgh K. (2001) Alterations in ApoE and ApoJ in relation to degeneration and regeneration in a mouse model of entorhinal cortex lesion. Exp. Neurol. 169, 307-318.
67. Wisniewski T., Golabek A., Matsubara E., Ghiso J. and Frangione B. (1993) Apolipoprotein E: binding to soluble Alzheimer's β-amyloid. Biochem. Biophys. Res. Commun. 192, 359-365.
68. Xu Q., Li Y., Cyras C., Sanan D. A. and Cordell B. (2000) Isolation and characterization of apolipoproteins from murine microglia. Identification of a low-density lipoprotein-like apolipoprotein J-rich but E-poor spherical particle. J. Biol. Chem. 275, 31770-31777.
69. Yates S. L., Burgess L. H., Kocsis-Angle J., Antal J. M., Dority M. D., Embury P. B., Piotrkowski A. M. and Brunden K. R. (2000) Amyloid beta and amylin fibrils induce increases in proinflammatory cytokine and chemokine production by THP-1 cells and murine microglia. J. Neurochem. 74, 1017-1025.
70. Zlokovic B. V., Martel C. L., Matsubara E., McComb J. G., Zheng G., McCluskey R. T., Frangione B. and Ghiso J. (1996) Glycoprotein330/megalin: probable role in receptor-mediated transport of apolipoprotein J alone and in a complex with Alzheimer's disease amyloid β at the blood-brain and blood-cerebrospinal fluid barriers. Proc. Natl Acad. Sci. USA 93, 4229-4234.
71. Zuckerman S. H. and O'Neal L. (1994) Endotoxin and GM-CSF- mediated downregulation of macrophage apo E secretion is inhibited by a TNF-specific monoclonal antibody. J. Leukoc. Biol. 55, 743-748.
72. Zwain I. H., Grima J. and Cheng C. Y. (1994) Regulation of clusterin secretion and mRNA expression in astrocytes by cytokines. Mol. Cell. Neurosci. 5, 229-237.